Funded Tech Companies

AdvanCell

Researching who provided funding to AdvanCell? Morningside Group joined the equity holders in this innovative biopharmaceutical company.

Company Overview

Company Name
AdvanCell
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
Level 7, Macquarie House, 167 Macquarie St,
Sydney, NSW, 2000
AU
Phone
Undisclosed
Email Address

Company Background Information

Overview
AdvanCell is a radiopharmaceutical company developing next-generation cancer treatments. AdvanCell's targeted alpha therapies are powered by a platform technology -- a world-first alpha isotope generator which addresses the greatest unmet need in targeted alpha therapy -- the reliable and scalable supply of isotope.
Profile
AdvanCell LinkedIn Company Profile
Social Media
AdvanCell Company Twitter Account
Company News
AdvanCell News
Facebook
AdvanCell on Facebook
YouTube
AdvanCell on YouTube
Last Transaction
8/24/2022

Financing History

Date
Type
Amount
Venture Equity
$18,000,000


Management Team

Title
Name
Email & Social
Chairman
Bill Ferris
  Bill Ferris LinkedIn Profile  Bill Ferris Twitter Account  Bill Ferris News  Bill Ferris on Facebook
Chief Executive Officer
Andrew Adamovich
  Andrew Adamovich LinkedIn Profile  Andrew Adamovich Twitter Account  Andrew Adamovich News  Andrew Adamovich on Facebook
Chief Technical Officer
Simon Puttick
  Simon Puttick LinkedIn Profile  Simon Puttick Twitter Account  Simon Puttick News  Simon Puttick on Facebook


Company Investors

  • Morningside Group (Anthony Aiudi)

 

 

 

Browse more funded tech companies:

AdvancedMD Software | AdvancePath

 

Share this article

 


About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary